Mecca - PT Kimia Farma (Persero) Tbk (KF) and Dwaa Medical Limited Company (Dwaa) has signed a Conditional Share Subscription Agrement (CSSA) in Mecca, Saudi Arabia (19/7).
The acquisition of shares Dwaa as stipulated in the CSSA, the shareholding in Dwaa will be 60% owned by KF Dwaa shares and 40% shares owned by shareholders Dwaa before.
CSSA signed by Honesti Basir, President Director of PT Kimia Farma (Persero) Tbk and Marei Bin Sheikh Mubarak bin Mahfoudz, Chairman Marei Bin Mahfoudz Group and witnessed by Mohamad Hery Saripudin, Consul General of the Republic of Indonesia and Untung Suseno Sutarjo, Secretary General of the Ministry of Health.
As a first step to enter new markets in the Middle East, KF investing in pharmaceutical companies in Saudi Arabia, which is a subsidiary of Marei Bin Mahfoudz Group to become a partner of Integrated Healthcare Business, with the field of wholesaler and retail Pharmaceutical & Health products, as well as the Management Services Health services. The presence of this joint venture will bring benefits for Umrah pilgrims, pilgrims Indonesia and workers who live in Saudi Arabia with the presence of 30 pharmaceutical outlets and two distribution centers in the prime location of Mecca and Jeddah.
On the occasion, Honesti conveyed, "The development of Kimia Farma business in Saudi Arabia is not limited only to hajj season but also to Umrah and Indonesian laborers in Saudi Arabia and the people of Saudi Arabia itself. Not only the need for drugs, we will also develop clinics and other health facilities. "
The presence of such pharmacies will provide an alternative to Indonesian citizens in addition to other pharmacies managed by Saudi Arabia where in the future the Company also plans to undertake the development of clinics and other health services in cooperation with other parties.
To continuously improve the growth rate of the Company's performance, management has designed a grand strategy for the construction of production facilities of the Company, namely Factory Banjaran, Salt Plant Pharmaceutical Plant Drug Raw Materials and in the near future will begin operation of Plant Rapid Test, which is a medical equipment test kit To perform the detection of diseases such as HIV, Siphilis, Malaria, Hepatitis, drugs and dengue fever.
In the optimization of assets, the Company optimizes its assets by partnering with strategic partners who are competent and experienced. Like the construction of MOXY Hotel in Dago Bandung, Hotel Development in Matraman Jakarta and Hospital Development in Saharjo Jakarta, with the form of Built Operate Transfer (BOT) cooperation.